Including genotype in the population pharmacokinetic model Among the 41 intensively sampled individuals, 26 (8 with C/C, 10 with C/T, 8 with C/T) had UGT1A1 rs887829 genotype information and when this was tested on dolutegravir clearance, there was a graded trend towards reduced clearance for C/T and T/T individuals of borderline significance.
← all excerpts
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.
1
—
—